GlassScriptPhysician profile
Rajiv Agarwal
NPI 1790027936
$862.15
in general payments reported to CMS, 2019-2025
6 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $134 · 2022: $229 · 2024: $154 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $362 · Travel and Lodging: $72.58 · Food and Beverage: $64.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $362.16 |
| Travel and Lodging | $72.58 |
| Food and Beverage | $64.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $264.83 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $228.84 | 2022 | |
| Taiho Oncology, INC. | $169.91 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $134.40 | 2020 | |
| Alnylam Pharmaceuticals INC. | $64.17 | 2025 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.